Stifel Financial Corp trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 28.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 206,738 shares of the exchange traded fund’s stock after selling 81,371 shares during the quarter. Stifel Financial Corp owned 0.27% of SPDR S&P Biotech ETF worth $18,620,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Golden State Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Lee Danner & Bass Inc. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $43,000.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA XBI opened at $80.25 on Friday. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. The firm has a 50 day simple moving average of $82.53 and a 200-day simple moving average of $90.52. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- CD Calculator: Certificate of Deposit Calculator
- Short Sellers Gave Up on These 3 Names Recently
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Boring Stocks Outperforming the Market This Year
- What is a Low P/E Ratio and What Does it Tell Investors?
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.